618 related articles for article (PubMed ID: 30735065)
1. Oncological outcomes of surgical treatment for T3 supraglottic laryngeal squamous cell carcinoma patients.
Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
Acta Otolaryngol; 2018 Nov; 138(11):1028-1034. PubMed ID: 30735065
[TBL] [Abstract][Full Text] [Related]
2. Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: Sixteen years of experience.
Vilaseca I; Blanch JL; Berenguer J; Grau JJ; Verger E; Muxí Á; Bernal-Sprekelsen M
Head Neck; 2016 Jul; 38(7):1050-7. PubMed ID: 26872432
[TBL] [Abstract][Full Text] [Related]
3. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.
Canis M; Ihler F; Martin A; Wolff HA; Matthias C; Steiner W
Head Neck; 2014 May; 36(5):652-9. PubMed ID: 23596018
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes of surgical treatment for T3 glottic laryngeal squamous cell carcinoma.
Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
Head Neck; 2018 Aug; 40(8):1734-1742. PubMed ID: 29601122
[TBL] [Abstract][Full Text] [Related]
5. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results.
Laccourreye O; Brasnu D; Biacabe B; Hans S; Seckin S; Weinstein G
Head Neck; 1998 Oct; 20(7):595-9. PubMed ID: 9744458
[TBL] [Abstract][Full Text] [Related]
6. Horizontal partial laryngectomy for supraglottic squamous cell carcinoma.
Bron LP; Soldati D; Monod ML; Mégevand C; Brossard E; Monnier P; Pasche P
Eur Arch Otorhinolaryngol; 2005 Apr; 262(4):302-6. PubMed ID: 15316823
[TBL] [Abstract][Full Text] [Related]
7. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
8. Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
Peretti G; Piazza C; Penco S; Santori G; Del Bon F; Garofolo S; Paderno A; Guastini L; Nicolai P
Head Neck; 2016 Jul; 38(7):1107-12. PubMed ID: 26970262
[TBL] [Abstract][Full Text] [Related]
9. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
[TBL] [Abstract][Full Text] [Related]
10. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
12. [Preservation of laryngeal function in surgical treatment of T3 supraglottic laryngeal carcinoma].
Zhang D; Luan X; Pan X; Xie G
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Nov; 20(21):977-9. PubMed ID: 17219995
[TBL] [Abstract][Full Text] [Related]
13. Treatment of early stage Supraglottic squamous cell carcinoma: meta-analysis comparing primary surgery versus primary radiotherapy.
Patel KB; Nichols AC; Fung K; Yoo J; MacNeil SD
J Otolaryngol Head Neck Surg; 2018 Mar; 47(1):19. PubMed ID: 29506564
[TBL] [Abstract][Full Text] [Related]
14. Lymph node density as an independent predictor of cancer-specific mortality in patients with lymph node-positive laryngeal squamous cell carcinoma after laryngectomy.
Ryu IS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
Head Neck; 2015 Sep; 37(9):1319-25. PubMed ID: 24828891
[TBL] [Abstract][Full Text] [Related]
15. Oncologic and functional outcomes of salvage supracricoid partial laryngectomy.
Kim JH; Kim WS; Koh YW; Kim SH; Byeon HK; Choi EC
Acta Otolaryngol; 2018 Dec; 138(12):1117-1122. PubMed ID: 30702020
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
Choi YS; Park SG; Song EK; Cho SH; Park MR; Park KU; Lee KH; Song IC; Lee HJ; Jo DY; Kim S; Yun HJ;
Head Neck; 2016 Aug; 38(8):1271-7. PubMed ID: 27043228
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of laryngectomy alone for treatment of locally advanced laryngeal cancer: A stage- and subsite-specific survival analysis.
Cervenka BP; Rao S; Farwell DG; Bewley AF
Clin Otolaryngol; 2018 Apr; 43(2):544-552. PubMed ID: 29054118
[TBL] [Abstract][Full Text] [Related]
18. Supracricoid partial laryngectomy in the management of t3 laryngeal cancer.
Mercante G; Grammatica A; Battaglia P; Cristalli G; Pellini R; Spriano G
Otolaryngol Head Neck Surg; 2013 Nov; 149(5):714-20. PubMed ID: 23921496
[TBL] [Abstract][Full Text] [Related]
19. Comparison of functional and oncological treatment outcomes after transoral robotic surgery and open surgery for supraglottic laryngeal cancer.
Karabulut B; Deveci I; Sürmeli M; Şahin-Yilmaz A; Oysu Ç
J Laryngol Otol; 2018 Sep; 132(9):832-836. PubMed ID: 30086810
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical outcomes of supracricoid partial laryngectomy with cricohyoidoepiglottopexy for glottic carcinoma.
Gong H; Zhou L; Wu H; Tao L; Chen X; Li X; Li C; Zhou J
Acta Otolaryngol; 2019 Sep; 139(9):803-809. PubMed ID: 31240973
[No Abstract] [Full Text] [Related]
[Next] [New Search]
